A gold storm is coming…
“We are in the early stages of a mania – the calm before the storm.”...
[Full Story]

PAA Insider Trading

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): A$30,300.00
Insider Selling (Last 12 Months): A$0.00

PharmAust Insider Trading History Chart

This chart shows the insider buying and selling history at PharmAust by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

PharmAust Share Price & Price History

Current Price: A$0.00
Price Change: +0.30 (1.20%)
As of 05/13/2020 01:00 AM ET

This chart shows the closing price history over time for PAA up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table

PharmAust Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/9/2023Sam WrightInsiderBuy165,000A$0.07A$11,550.00
9/13/2022Sam WrightInsiderBuy250,000A$0.08A$18,750.00
11/9/2021Roger AstonInsiderIssued3,649,904A$0.01A$36,499.04
8/24/2021Sam WrightInsiderBuy500,000A$0.09A$42,500.00
See Full Table

SEC Filings (Institutional Ownership Changes) for PharmAust (ASX:PAA)

PharmAust Limited develops targeted cancer therapeutics for humans and animals in Switzerland, Australia, Sweden, the United States, and internationally. The company develops drug discovery intellectual property for the treatment of various cancers, and neurological diseases. Its lead candidate is Monepantel (MPL), a small molecule drug which is in Phase II clinical trials for the treatment of cancer. The company also provides products and services in synthetic and medicinal chemistry to the drug discovery and pharmaceutical industries worldwide. The company has a research agreement with the Walter and Eliza Hall Institute to investigate the effects of MPL upon human T-lymphotrophic virus-1 (HTLV-1) infections in vitro. It serves drug discovery and pharmaceutical industries. PharmAust Limited was incorporated in 2000 and is based in Bentley, Australia.
Read More on PharmAust

Today's Range

Now: N/A

50 Day Range

MA: N/A

52 Week Range

Now: N/A

Volume

3,268,637 shs

Average Volume

N/A

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of PharmAust?

PharmAust's top insider shareholders include:
  1. Roger Aston (Insider)
  2. Sam Wright (Insider)
Learn More about top insider investors at PharmAust.
A gold storm is coming…
“We are in the early stages of a mania – the calm before the storm.”...
[Full Story]